Technologies
Title: | Repurposing of Colchicine for COVID-19 treatment |
Area: | Life Sciences & Biotechnology, Pharmaceutical Sciences, COVID-19 Technology |
Focus Area: | Development of Repurposed Drugs for COVID-19 |
Company Transferred: | Laxai Life Sciences, Hyderabad |
Developing Agency: | Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu; Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad |
| Website Link : | https://www.iictindia.org/; |
Brief Description
Description : | This is a FDA approved drug for gout. Tablets are available with the Cadila. The same dose of tablets (0.5 mg) is propsoed to be used for COVID-19 trial. The clinical trial strategy for conducting Phase II clinical trial of colchicine along with a comparative arm of SoC, has been prepared. |